Calcium channel blockers: A new hope for pregnant women with vasospastic angina

A woman with hopes to conceive was diagnosed with severe vasospastic angina (VSA); however, she was able to carry a healthy baby to full term without angina attacks after starting treatment of a calcium channel blocker, according to a case published in a special Cardio-Obstetrics issue of JACC: Case Reports.

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (370) Merck (239) AstraZeneca (190) Novartis (162) AbbVie (145) BeiGene (136) Pfizer (123) F. Hoffmann-La Roche (122)

December 23, 2023

Vertex’s non-opioid pain drug is approved by FDA, bringing first of new class to market

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

February 1, 2025

Emergent seeking to reverse fortunes and become a major overdose treatment player

Emergent BioSolutions (Gaithersburg, US) has purchased US and Canadian rights to Kloxxado, adding to its opioid overdose treatment portfolio, which includes Narcan. The growing US

January 23, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.